Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression. [electronic resource]
Producer: 20100908Description: 292-6 p. digitalISSN:- 1720-8386
- Animals
- Diabetes Mellitus, Experimental -- drug therapy
- Diabetic Nephropathies -- pathology
- Enzyme-Linked Immunosorbent Assay
- Epithelial Cells -- pathology
- Gene Expression Regulation, Enzymologic -- drug effects
- Glomerular Basement Membrane -- enzymology
- Glycated Hemoglobin -- metabolism
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- pharmacology
- Kidney -- pathology
- Lipids -- blood
- Male
- Matrix Metalloproteinase 9 -- biosynthesis
- Matrix Metalloproteinase Inhibitors
- Microscopy, Electron
- Organ Size -- physiology
- RNA, Messenger -- biosynthesis
- Rats
- Rats, Wistar
- Reverse Transcriptase Polymerase Chain Reaction
- Simvastatin -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.